Sabitlenmiş Tweet

We are no longer accepting applicants for our open-label mechanistic study on Psilocybin for fibromyalgia, thank you for those who applied, watch this space for updates and results. clinicaltrials.gov/study/NCT05548… @juliabornemann @Dr_Kirran @RCarhartHarris @ProfDavidNutt

English











